Engineers Gate Manager LP Travere Therapeutics, Inc. Transaction History
Engineers Gate Manager LP
- $5.55 Billion
- Q1 2025
A detailed history of Engineers Gate Manager LP transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 89,784 shares of TVTX stock, worth $1.55 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
89,784Holding current value
$1.55 Million% of portfolio
0.03%Shares
11 transactions
Others Institutions Holding TVTX
# of Institutions
234Shares Held
101MCall Options Held
1.79MPut Options Held
540K-
Armistice Capital, LLC New York, NY8.87MShares$153 Million2.42% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$132 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X07.53MShares$130 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.01MShares$86.4 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.8MShares$82.7 Million0.11% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.11B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...